A phosphoproteomic study by researchers at the University of California, Los Angeles has found that prostate cancer metastases in different organs in the same patient share similar tyrosine kinase activation profiles.

The finding raises the possibility that personalized treatment based on analysis of a biopsy from a single metastatic lesion could prove effective across multiple sites, said Justin Drake, a postdoctoral fellow in the lab of UCLA research Owen Witte, which led the study.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.